Comparison of Autologous Hematopoietic Cell Transplantation and Chemotherapy as Postremission Treatment in Non-M3 Acute Myeloid Leukemia in First Complete Remission-Reference-Cited by-同舟云学术

Comparison of Autologous Hematopoietic Cell Transplantation and Chemotherapy as Postremission Treatment in Non-M3 Acute Myeloid Leukemia in First Complete Remission

Published:2012-12 Issue:6 Volume:12 Page:444-451
ISSN:2152-2650
Container-title:Clinical Lymphoma Myeloma and Leukemia
language:en
Short-container-title:Clinical Lymphoma Myeloma and Leukemia

Author:

Usuki Kensuke,Kurosawa Saiko,Uchida Naoyuki,Yakushiji Kazuaki,Waki Fusako,Matsuishi Eijo,Kagawa Kumiko,Furukawa Tatsuo,Maeda Yoshinobu,Shimoyama Manabu,Ago Hiroatsu,Yamano Yujiro,Yano Shingo,Fujishima Naohito,Takamatsu Yasushi,Eto Tetsuya,Hidaka Michihiro,Matsuoka Hitoshi,Fukuda Takahiro

Funder

Japanese Ministry of Health, Labour and Welfare

Advanced Clinical Research Organization

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology

Reference44 articles.

1. How I treat acute myeloid leukemia;Rowe;Blood,2010

2. Is there a role for autotransplants in AML in first remission?;Seshadri;Biol Blood Marrow Transplant,2009

3. Autologous stem cell transplantation for acute myeloid leukemia;Linker;Bone Marrow Transplant,2003

4. Acute myeloid leukemia and the position of autologous stem cell transplantation;Breems;Semin Hematol,2007

5. Autologous hematopoietic stem cell transplantation as an intensive consolidation therapy for adult patients in remission from acute myelogenous leukemia;Jung;Biol Blood Marrow Transplant,2009

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of allo-SCT, auto-SCT and chemotherapy for the treatment of patients with low- or intermediate-risk acute myeloid leukemia: a network meta-analysis;Stem Cell Research & Therapy;2024-05-31

2. Auto-hematopoietic stem cell transplantation or chemotherapy? Meta-analysis of clinical choice for AML;Annals of Hematology;2024-01-25

3. Autologous stem cell transplantation in adult patients with intermediate-risk acute myeloid leukemia in first complete remission and no detectable minimal residual disease. A comparative retrospective study with haploidentical transplants of the global committee and the ALWP of the EBMT;Bone Marrow Transplantation;2023-08-28

4. Safety and efficacy of a modified busulfan/cyclophosphamide conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation in acute myeloid leukemia;Frontiers in Pharmacology;2023-02-03

5. Syngeneic hematopoietic stem cell transplantation for acute myeloid leukemia: a propensity score-matched analysis;Blood Cancer Journal;2021-09